Similarly, when DBCCR1 levels in 12 representative lung cancer patients were specifically analyzed (Figure 1A), low DBCCR1 expressions were correlated with more advanced stages of tumor, with significantly decreased DBCCR1 in late stages of cancer (II, III and IV, p<0.01 as compared to I, respectively). This evidence concerns the gene BRINP1 and neoplasm.